BRAINBox Solutions Announces Enrollment Begins in Pivotal, HeadSMART II Clinical Study of BRAINBox TBI Concussion Diagnostic and Prognostic Test
BRAINBox Solutions Announces Enrollment Begins in Pivotal, HeadSMART II Clinical Study of BRAINBox TBI Concussion Diagnostic and Prognostic Test News provided by Share this article Share this article RICHMOND, Va., Dec. 16, 2020 /PRNewswire/ -- BRAINBox Solutions today announced it is beginning enrollment in its pivotal clinical trial, HeadSMART II ( Head injury Response to Trauma), of the company's concussion diagnostic and prognostic test, BRAINBox TBI. The multi-national, multi-site trial, which will enroll up to 2,000 patients, aims to generate data to support an application for regul...